Characteristic | Weekly docetaxel (n = 41) | 3-weekly docetaxel (n = 41) | P-value | ||
---|---|---|---|---|---|
 | No. | (%) | No. | (%) |  |
Age (years) | Â | Â | Â | Â | 0.38 |
   Mean | 50.1 | 48.3 |  | ||
   Range | 27-68 | 32-70 |  | ||
Age at entry (years) | Â | Â | Â | Â | 0.08 |
   ≤50 | 17 | 42 | 25 | 61 |  |
   >50 | 24 | 58 | 16 | 39 |  |
Menopausal status | Â | Â | Â | Â | 0.66 |
   Premenopausal | 22 | 54 | 24 | 58 |  |
   Postmenopausal | 19 | 46 | 17 | 42 |  |
Tumour size (cm) by caliper | Â | Â | Â | Â | 0.41 |
   Mean | 4.1 | 4.3 |  | ||
   Range | 2.0-6.2 | 2.5-11.4 |  | ||
Tumour size (cm) by ultrasound | Â | Â | Â | Â | 0.40 |
   Mean | 2.3 | 2.4 |  | ||
   Range | 0.9-4.6 | 1.0-4.7 |  | ||
Tumour stage | Â | Â | Â | Â | 0.77 |
   T1 | 1 | 2 | 0 | 0 |  |
   T2 | 32 | 79 | 35 | 86 |  |
   T3 | 7 | 17 | 5 | 12 |  |
   T4 | 1 | 2 | 1 | 2 |  |
Tumour type | Â | Â | Â | Â | 0.48 |
   Invasive ductal | 35 | 85 | 38 | 93 |  |
   Invasive lobular | 6 | 15 | 3 | 7 |  |
Tumour grade | Â | Â | Â | Â | 0.21 |
   1 | 5 | 12 | 1 | 2 |  |
   2 | 16 | 39 | 15 | 37 |  |
   3 | 20 | 49 | 25 | 61 |  |
Clinical staging | Â | Â | Â | Â | 0.39 |
   IIA | 22 | 53 | 15 | 37 |  |
   IIB | 15 | 37 | 18 | 44 |  |
   IIIA | 2 | 5 | 3 | 7 |  |
   IIIB | 2 | 5 | 5 | 12 |  |
Oestrogen receptor status | Â | Â | Â | Â | 0.24 |
   Positive | 31 | 76 | 25 | 61 |  |
   Negative | 10 | 24 | 15 | 37 |  |
   Unknown | 0 | 0 | 1 | 2 |  |
Progesterone receptor status | Â | Â | Â | Â | 0.09 |
   Positive | 21 | 51 | 13 | 32 |  |
   Negative | 13 | 32 | 23 | 56 |  |
   Unknown | 7 | 17 | 5 | 12 |  |